Sentiment-Signal
25,0
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 10.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; A |
| 28.07.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | t to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App |
Stammdaten
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Unternehmen & Branche
| Name | Elevance Health, Inc. |
|---|---|
| Ticker | ELV |
| CIK | 0001156039 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Plans |
| SIC | 6324 · Hospital & Medical Service Plans |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 79,35 Mrd. USD |
| Beta | 0,50 |
| Dividendenrendite | 6,85 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 50,181,000,000 | 1,764,000,000 | 8.00 | 125,827,000,000 | 43,902,000,000 |
| 2025-12-31 | 10-K | 199,125,000,000 | 5,662,000,000 | 25.21 | 121,494,000,000 | 43,882,000,000 |
| 2025-09-30 | 10-Q | 50,711,000,000 | 1,189,000,000 | 5.32 | 122,749,000,000 | 43,953,000,000 |
| 2025-06-30 | 10-Q | 49,776,000,000 | 1,743,000,000 | 7.72 | 121,938,000,000 | 43,722,000,000 |
| 2025-03-31 | 10-Q | 48,891,000,000 | 2,183,000,000 | 9.61 | 119,717,000,000 | 42,503,000,000 |
| 2024-12-31 | 10-K | 177,011,000,000 | 5,980,000,000 | 25.68 | 116,889,000,000 | 41,315,000,000 |
| 2024-09-30 | 10-Q | 45,106,000,000 | 1,016,000,000 | 4.36 | 116,533,000,000 | 43,775,000,000 |
| 2024-06-30 | 10-Q | 43,886,000,000 | 2,300,000,000 | 9.85 | 112,988,000,000 | 42,191,000,000 |
| 2024-03-31 | 10-Q | 42,577,000,000 | 2,246,000,000 | 9.59 | 111,894,000,000 | 40,608,000,000 |
| 2023-12-31 | 10-K | 171,340,000,000 | 5,987,000,000 | 25.22 | 108,928,000,000 | 39,306,000,000 |
| 2023-09-30 | 10-Q | 42,849,000,000 | 1,289,000,000 | 5.45 | 110,478,000,000 | 38,423,000,000 |
| 2023-06-30 | 10-Q | 43,672,000,000 | 1,853,000,000 | 7.79 | 109,168,000,000 | 38,205,000,000 |
| 2023-03-31 | 10-Q | 42,172,000,000 | 1,989,000,000 | 8.30 | 109,040,000,000 | 37,356,000,000 |
| 2022-12-31 | 10-K | 156,595,000,000 | 5,894,000,000 | 24.28 | 102,755,000,000 | 36,243,000,000 |
| 2022-12-31 | 10-Q | 156,595,000,000 | 5,894,000,000 | 24.28 | 102,755,000,000 | 36,243,000,000 |
| 2022-09-30 | 10-Q | 39,939,000,000 | 1,603,000,000 | 6.62 | 103,026,000,000 | 36,055,000,000 |
| 2022-06-30 | 10-Q | 38,632,000,000 | 1,637,000,000 | 6.73 | 100,877,000,000 | 35,812,000,000 |
| 2022-03-31 | 10-Q | 38,095,000,000 | 1,789,000,000 | 7.32 | 100,486,000,000 | 35,975,000,000 |
| 2021-12-31 | 10-K | 138,639,000,000 | 6,158,000,000 | 24.95 | 97,460,000,000 | 36,060,000,000 |
| 2021-12-31 | 10-Q | 138,639,000,000 | 6,158,000,000 | 24.95 | 97,456,000,000 | 36,095,000,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | SCHULMAN AMY W | Director | Open Market Sale | -26 | 287.50 | -7,475.00 | -1,1% | |
| 2026-03-06 | Kendrick Charles Morgan JR | Officer, EVP & President, Commercial | Open Market Sale | -3,196 | 284.92 | -910,604.32 | -138,5% | |
| 2026-03-05 | COLLIS STEVEN H | Director | Open Market Purchase | 3,000 | 289.84 | 869,520.00 | +132,3% | |
| 2025-08-19 | DeVore Susan D. | Director | Open Market Purchase | 1,200 | 312.15 | 374,580.00 | +57,0% | |
| 2025-07-18 | BOUDREAUX GAIL | Director, Officer, President and CEO | Open Market Purchase | 1,050 | 287.96 | 302,358.00 | +46,0% | |
| 2025-07-18 | BOUDREAUX GAIL | Director, Officer, President and CEO | Open Market Purchase | 5,116 | 287.12 | 1,468,905.92 | +223,5% | |
| 2025-07-18 | BOUDREAUX GAIL | Director, Officer, President and CEO | Open Market Purchase | 2,334 | 286.07 | 667,687.38 | +101,6% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.